Zobrazeno 1 - 10
of 155
pro vyhledávání: '"E, Yayoi"'
Autor:
M, Yamasaki, E, Yayoi, M, Kishibuchi, T, Nishi, T, Yagyu, K, Kawasaki, V, Ostapenko, T, Nishide
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 28(11)
A 59-year-old woman was admitted to our hospital because of massive bleeding from a right breast tumor. The breast tumor had existed for ten years occupied the entire right breast (23 x 20 cm), its central part forming an ulcer 17 x 15 cm in size. Ra
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine.
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 26(12)
A 55-year-old woman was seen in our clinic for liver metastases of breast cancer. She underwent a standard radical mastectomy in June, 1987. Five years and 3 months after the operation, multiple bone metastases were found on bone scintigram and 10 ye
Autor:
M, Monden, H, Nakamura, E, Yayoi, T, Monden, H, Ohi, J, Arisawa, M, Masuzawa, T, Shimizu, N, Tomono, K, Seki, N, Nakao, A, Todo, Y, Inoue, M, Sakon, Y, Ohsaki, T, Hosoki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 25(11)
A 10-center cooperative clinical study with a new formulation of epirubicin hydrochloride injectable solution (Epirubicin-RTU) was conducted in patients with hepatocellular carcinoma. Epirubicin-RTU 60 mg/m2 was injected into the hepatic artery and a
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 25(9)
Between 1986 and 1997, we treated 55 patients with liver metastases of breast cancer. In this study, the clinical features and effects of systemic or intra-arterial chemo-endocrine therapy for these patients were reviewed to clarify the characteristi
Autor:
N, Masuda, E, Yayoi, J, Furukawa, S, Maruhashi, M, Tokunaga, S, Takiguchi, S, Matsui, H, Yano, H, Tateishi, M, Kinuta, H, Maruyama, J, Okamura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 25(6)
A total of 91 breast cancer patients died of advanced and recurrent breast cancer at the Osaka Teishin Hospital from 1986 to 1996. There were 18 cases (19.8%) among them showing hypercalcemia (serum corrected Caor = 11.0 mg/dl). These 18 cases were a
Autor:
S J, Kim, E, Shiba, T, Kobayashi, E, Yayoi, J, Furukawa, Y, Takatsuka, E, Shin, H, Koyama, H, Inaji, S, Takai
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(1)
Urokinase-type plasminogen activator (u-PA) is a key protease in cancer invasion and metastasis. Recent studies demonstrated that u-PA, plasminogen activator inhibitor type-1 (PAI-1), and tissue-type plasminogen activator (t-PA) are prognostic factor
Autor:
H, Tateishi, H, Oi, N, Masuda, H, Yano, S, Matsui, M, Kinuta, H, Maruyama, E, Yayoi, J, Okamura
Publikováno v:
Seminars in oncology. 24(2 Suppl 6)
Since 1988, 124 patients with hepatocellular carcinoma were treated in our departments. Among them, 31 cases treated by surgical resection and 30 cases administered a combination therapy (Lipiodol [Laboratoire Guerbet, Villepinte, France]-transcathet
Autor:
N, Masuda, E, Yayoi, J, Furukawa, S, Maruhashi, M, Tokunaga, S, Takiguchi, S, Matsui, H, Yano, H, Tateishi, M, Kinuta, H, Maruyama, H, Ooi, J, Okamura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 23(11)
Twelve patients with liver metastases of breast cancer were treated with hepatic arterial infusion chemotherapy using 20-30 mg/body of epi-adriamycin (epi-ADM) every 2 weeks and continuous infusion of 250 mg/body/day of 5-fluorouracil (5-FU). All pat
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 22(11)
Seventeen patients with liver metastases of breast cancer were treated with a combination of intra-arterial chemotherapy and endocrine therapy at our hospital from 1986 to 1994. Of 17 patients, 9 were treated with transarterial chemoembolization thro